PT Ekadharma International Tbk Statistics
PT Ekadharma International Tbk (EKAD) Stock Statistics & Valuation Metrics
Total Valuation
PT Ekadharma International Tbk has a market cap or net worth of IDR 1.09T. The enterprise value is IDR 815.97B.
- Market Cap
- IDR 1.09T
- Enterprise Value
- IDR 815.97B
Share Statistics
PT Ekadharma International Tbk has 3,493,875,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 3,493,875,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
PT Ekadharma International Tbk’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 3.31%.
- Return on Equity (ROE)
- 0.04
- Return on Assets (ROA)
- 0.04
- Return on Invested Capital (ROIC)
- 3.31%
- Return on Capital Employed (ROCE)
- 0.04
- Revenue Per Employee
- 884.02M
- Profits Per Employee
- 88.52M
- Employee Count
- 599
- Asset Turnover
- 0.39
- Inventory Turnover
- 2.07
Valuation Ratios
The current PE Ratio of PT Ekadharma International Tbk is 13.88. PT Ekadharma International Tbk’s PEG ratio is 0.09.
- PE Ratio
- 13.88
- PS Ratio
- 1.87
- PB Ratio
- 0.86
- Price to FCF
- 11.48
- Price to Operating Cash Flow
- 10.41
- PEG Ratio
- 0.09
Income Statement
In the last 12 months, PT Ekadharma International Tbk had revenue of 529.53B and earned 53.02B in profits. Earnings per share was 15.18.
- Revenue
- 529.53B
- Gross Profit
- 147.27B
- Operating Income
- 52.13B
- Pretax Income
- 61.78B
- Net Income
- 53.02B
- EBITDA
- 75.10B
- Earnings Per Share (EPS)
- 15.18
Cash Flow
In the last 12 months, operating cash flow was 89.72B and capital expenditures -8.75B, giving a free cash flow of 80.97B billion.
- Operating Cash Flow
- 89.72B
- Free Cash Flow
- 80.97B
- Free Cash Flow per Share
- 27.17
Dividends & Yields
PT Ekadharma International Tbk pays an annual dividend of ―, resulting in a dividend yield of 2.88%
- Dividend Per Share
- ―
- Dividend Yield
- 2.88%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 8.71%
- Earnings Yield
- 7.21%
Stock Price Statistics
- Beta
- 0.59
- 52-Week Price Change
- 65.08%
- 50-Day Moving Average
- 367.76
- 200-Day Moving Average
- 230.13
- Relative Strength Index (RSI)
- 41.61
- Average Volume (3m)
- 12.47M
Important Dates
PT Ekadharma International Tbk upcoming earnings date is Apr 01, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 30, 2026
- Next Earnings Date
- Apr 01, 2027
- Ex-Dividend Date
- ―
Financial Position
PT Ekadharma International Tbk as a current ratio of 14.07, with Debt / Equity ratio of 1.87%
- Current Ratio
- 14.07
- Quick Ratio
- 10.84
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- -0.76
- Interest Coverage Ratio
- 30.05
Taxes
In the past 12 months, PT Ekadharma International Tbk has paid 9.95B in taxes.
- Income Tax
- 9.95B
- Effective Tax Rate
- 0.16
Enterprise Valuation
PT Ekadharma International Tbk EV to EBITDA ratio is 11.69, with an EV/FCF ratio of 10.62.
- EV to Sales
- 1.73
- EV to EBITDA
- 11.69
- EV to Free Cash Flow
- 10.62
- EV to Operating Cash Flow
- 9.63
Balance Sheet
PT Ekadharma International Tbk has IDR 518.70B in cash and marketable securities with IDR 26.84B in debt, giving a net cash position of IDR 491.86B billion.
- Cash & Marketable Securities
- IDR 518.70B
- Total Debt
- IDR 26.84B
- Net Cash
- IDR 491.86B
- Net Cash Per Share
- IDR 140.78
- Tangible Book Value Per Share
- IDR 362.31
Margins
Gross margin is 32.54%, with operating margin of 11.91%, and net profit margin of 13.48%.
- Gross Margin
- 32.54%
- Operating Margin
- 11.91%
- Pretax Margin
- 16.25%
- Net Profit Margin
- 13.48%
- EBITDA Margin
- 14.80%
- EBIT Margin
- 10.47%
Analyst Forecast
The average price target for PT Ekadharma International Tbk is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 10.52%
- EPS Growth Forecast
- 149.38%
